Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies
NoticeFDA-2026-N-3532-0001
Comments
2
Awaiting comments
Deadline
4 days
Closes Jun 30, 2026
Net supportiSupport minus oppose · campaigns included
-50%
-50% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Agency Information Collection Activities; Proposed Collection; Comment Request; Good Laboratory Practice Requirements for Nonclinical Laboratory Studies
- Posted
- Apr 30, 2026
- Comment period
- Apr 30, 2026 – Jun 30, 2026
- FR Doc
- 2026-08371
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
-50%
Net support
Oppose1Other1
Aggregates include form-letter campaigns. Excluding them, net support is -50% across organic comments.
Who commented
Breakdown by commenter type.
Individual
2
Comments over time
Weekly arrivals, stacked by stance.
Posted Apr 30, 2026Deadline Jun 30, 2026
Apr 27
Support0Oppose1Other1
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
0%
50%
50%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
Filter:
- May 1, 2026Comment from Mary FosterOpposeIndividual
An individual is expressing concern that the proposed Good Laboratory Practice (GLP) requirements will negatively impact the availability of affordable medications from compounding pharmacies. They argue that these regulations could force patients with specific health conditions to seek unregulated medications because their insurance does not cover the drugs.
Read comment → - Apr 30, 2026Comment from Kay BryanOtherIndividualRead comment →